173 related articles for article (PubMed ID: 33408691)
21. The effect of L-carnitine supplementation on insulin resistance, sex hormone-binding globulin and lipid profile in overweight/obese women with polycystic ovary syndrome: a randomized clinical trial.
Sangouni AA; Pakravanfar F; Ghadiri-Anari A; Nadjarzadeh A; Fallahzadeh H; Hosseinzadeh M
Eur J Nutr; 2022 Apr; 61(3):1199-1207. PubMed ID: 34727201
[TBL] [Abstract][Full Text] [Related]
22. Relationship between body composition, insulin resistance, and hormonal profiles in women with polycystic ovary syndrome.
Zhang H; Wang W; Zhao J; Jiao P; Zeng L; Zhang H; Zhao Y; Shi L; Hu H; Luo L; Fukuzawa I; Li D; Li R; Qiao J
Front Endocrinol (Lausanne); 2022; 13():1085656. PubMed ID: 36699018
[TBL] [Abstract][Full Text] [Related]
23. The effect of marjoram (Origanum majorana) tea on the hormonal profile of women with polycystic ovary syndrome: a randomised controlled pilot study.
Haj-Husein I; Tukan S; Alkazaleh F
J Hum Nutr Diet; 2016 Feb; 29(1):105-11. PubMed ID: 25662759
[TBL] [Abstract][Full Text] [Related]
24. The Effects of Myo-Inositol and D-Chiro-Inositol in a Ratio 40:1 on Hormonal and Metabolic Profile in Women with Polycystic Ovary Syndrome Classified as Phenotype A by the Rotterdam Criteria and EMS-Type 1 by the EGOI Criteria.
Pustotina O; Myers SH; Unfer V; Rasulova I
Gynecol Obstet Invest; 2024; 89(2):131-139. PubMed ID: 38295772
[TBL] [Abstract][Full Text] [Related]
25. The effect of vitamin D supplementation in combination with low-calorie diet on anthropometric indices and androgen hormones in women with polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial.
Jafari-Sfidvajani S; Ahangari R; Hozoori M; Mozaffari-Khosravi H; Fallahzadeh H; Nadjarzadeh A
J Endocrinol Invest; 2018 May; 41(5):597-607. PubMed ID: 29110281
[TBL] [Abstract][Full Text] [Related]
26. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome.
Fenkci SM; Fenkci V; Oztekin O; Rota S; Karagenc N
Hum Reprod; 2008 Jul; 23(7):1602-6. PubMed ID: 18378560
[TBL] [Abstract][Full Text] [Related]
27. The effects of quercetin supplementation on metabolic and hormonal parameters as well as plasma concentration and gene expression of resistin in overweight or obese women with polycystic ovary syndrome.
Khorshidi M; Moini A; Alipoor E; Rezvan N; Gorgani-Firuzjaee S; Yaseri M; Hosseinzadeh-Attar MJ
Phytother Res; 2018 Nov; 32(11):2282-2289. PubMed ID: 30062709
[TBL] [Abstract][Full Text] [Related]
28. Effects of selenium supplementation on glucose homeostasis and free androgen index in women with polycystic ovary syndrome: A randomized, double blinded, placebo controlled clinical trial.
Mohammad Hosseinzadeh F; Hosseinzadeh-Attar MJ; Yekaninejad MS; Rashidi B
J Trace Elem Med Biol; 2016 Mar; 34():56-61. PubMed ID: 26854246
[TBL] [Abstract][Full Text] [Related]
29. Long-term treatment with the combination ethinylestradiol and cyproterone acetate in polycystic ovary syndrome.
Falsetti L; Galbignani E
Contraception; 1990 Dec; 42(6):611-9. PubMed ID: 2150631
[TBL] [Abstract][Full Text] [Related]
30. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ
Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948
[TBL] [Abstract][Full Text] [Related]
31. AMH in combination with SHBG for the diagnosis of polycystic ovary syndrome.
Calzada M; López N; Noguera JA; Mendiola J; Hernández AI; Corbalán S; Sanchez M; Torres AM
J Obstet Gynaecol; 2019 Nov; 39(8):1130-1136. PubMed ID: 31208261
[TBL] [Abstract][Full Text] [Related]
32. The effect of abdominal obesity in patients with polycystic ovary syndrome on metabolic parameters.
Franik G; Bizoń A; Włoch S; Pluta D; Blukacz Ł; Milnerowicz H; Madej P
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4755-4761. PubMed ID: 29164590
[TBL] [Abstract][Full Text] [Related]
33. The effects of synbiotic supplementation on hormonal status, biomarkers of inflammation and oxidative stress in subjects with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.
Nasri K; Jamilian M; Rahmani E; Bahmani F; Tajabadi-Ebrahimi M; Asemi Z
BMC Endocr Disord; 2018 Apr; 18(1):21. PubMed ID: 29649996
[TBL] [Abstract][Full Text] [Related]
34. Effect of metformin on clinical, metabolic and endocrine outcomes in women with polycystic ovary syndrome: a meta-analysis of randomized controlled trials.
Patel R; Shah G
Curr Med Res Opin; 2017 Sep; 33(9):1545-1557. PubMed ID: 28058854
[TBL] [Abstract][Full Text] [Related]
35. Serum Fetuin-A levels, insulin resistance and oxidative stress in women with polycystic ovary syndrome.
Enli Y; Fenkci SM; Fenkci V; Oztekin O
Gynecol Endocrinol; 2013 Dec; 29(12):1036-9. PubMed ID: 23961784
[TBL] [Abstract][Full Text] [Related]
36. Eight-hour time-restricted feeding improves endocrine and metabolic profiles in women with anovulatory polycystic ovary syndrome.
Li C; Xing C; Zhang J; Zhao H; Shi W; He B
J Transl Med; 2021 Apr; 19(1):148. PubMed ID: 33849562
[TBL] [Abstract][Full Text] [Related]
37. [CORRELATION OF ANTI-MULLERIAN HORMONE WITH HORMONAL AND OVARIAN MORPHOLOGICAL CHARACTERISTICS IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME WITH AND WITHOUT INSULIN RESISTANCE].
Asanidze E; Khristesashvili J; Pkhaladze L; Barbakadze L
Georgian Med News; 2018 Feb; (Issue):34-40. PubMed ID: 29578420
[TBL] [Abstract][Full Text] [Related]
38. The effects of coenzyme Q10 supplementation on metabolic profiles and parameters of mental health in women with polycystic ovary syndrome.
Karamali M; Gholizadeh M
Gynecol Endocrinol; 2022 Jan; 38(1):45-49. PubMed ID: 34664527
[TBL] [Abstract][Full Text] [Related]
39. Anteroposterior diameter of the infrarenal abdominal aorta is higher in women with polycystic ovary syndrome.
Ciccone MM; Favale S; Bhuva A; Scicchitano P; Caragnano V; Lavopa C; De Pergola G; Loverro G
Vasc Health Risk Manag; 2009; 5(3):561-6. PubMed ID: 19590590
[TBL] [Abstract][Full Text] [Related]
40. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study.
Singh S; Akhtar N; Ahmad J
Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]